BLFS - Company ID 0000834365
The table below shows BIOLIFE SOLUTIONS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $96.21M | $74.65M | $68.02M | $76.24M | $119.16M | $48.09M |
| Cost of revenue | $34.10M | $24.55M | $26.70M | - | - | - |
| Gross profit | $62.12M | $50.10M | $41.32M | - | - | - |
| R&D | $7.57M | $4.75M | $5.51M | $8.67M | $11.82M | $6.72M |
| SG&A |
BIOLIFE SOLUTIONS INC reported annual revenue of $96.21M for fiscal year 2025. That is up 28.9% from $74.65M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $6.19M (FY 2014) to $96.21M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $45.52M |
| $40.63M |
| $42.79M |
| $33.26M |
| $33.67M |
| $15.27M |
| Operating income | -$16.60M | -$4.48M | -$17.20M | -$5.92M | -$35.16M | -$6.24M |
| Income tax | $49.00K | -$38.00K | -$64.00K | -$5.24M | -$20.12M | -$3.26M |
| Net income | -$4.59M | -$20.18M | -$68.00M | -$139.81M | -$8.91M | $1.98M |
| EPS (diluted) | -$0.10 | -$0.44 | -$1.55 | -$3.25 | -$0.23 | -$0.06 |